chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Vaccination site discomfort, Vaccination site pain
Clinical narrative: Post injection site pain; Left arm feels heavy around injection site; Left arm tingling; This is a spontaneous report from a non-contactable nurse, the patient. A 49-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0186) via an unspecified route of administration in the left arm on 20Aug2021 at 12:30 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included migraines. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0179) via an unspecified route of administration in the left arm on 30Jul2021 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. On 20Aug2021 at 12:30, the patient experienced post injection site pain, left arm felt heavy around injection site and left arm tingling. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events post injection site pain, left arm felt heavy around injection site and left arm tingling was not resolved at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Erythema, Vaccination site pain, Vaccination site swelling
Clinical narrative: Pain in arm at injection site; Swelling at injection site; Red face and chest upon waking day after; Dizziness upon waking; This is a spontaneous report from a non-contactable consumer, the patient. A 59-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0175) via an unspecified route of administration on an unknown date in Aug2021 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included only allergies and known allergies to medications, some foods, some trees, yeast and mold and bee venom. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included pseudoephedrine hydrochloride (SUDAFED), cetirizine hydrochloride (ZYRTEC) and ibuprofen (ADVIL); all for unknown indications from unknown dates and unknown if ongoing. On an unknown date in Aug2021, the patient experienced pain in arm at injection site, swelling at injection site, red face and chest upon waking day after but subsided within 2 hours and dizziness upon waking, subsided in a few hours. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events red face and chest upon waking day after and dizziness upon waking was resolved on an unknown date in Aug2021. The clinical outcome of the events pain in arm at injection site and swelling at injection site was not resolved at the time of this report.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Axillary pain, Fatigue, Feeling hot, Headache
Clinical narrative: Body aches; Fatigue; Low energy; Right arm pain tingling to fingertips; Right arm pain tingling to fingertips; Under armpit pain; Headache; Hot; This is a spontaneous report from a non-contactable consumer, the patient. A 42-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 18Aug2021 at 13:30 as a single dose for COVID-19 immunisation. Medical history included parathyroid gland excision and hypothyroidism. The patient previously took sulfur (MANUFACTURER UNKNOWN) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration as a single dose for COVID-19 immunisation. On 19Aug2021 at 00:00, the patient experienced right arm pain tingling to fingertips, under armpit pain, headache, hot, body aches, fatigue, low energy. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care.  Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events right arm pain tingling to fingertips, under armpit pain, headache, hot, body aches, fatigue, low energy was recovering at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity, Paraesthesia
Clinical narrative: Body aches; Fatigue; Low energy; Right arm pain tingling to fingertips; Right arm pain tingling to fingertips; Under armpit pain; Headache; Hot; This is a spontaneous report from a non-contactable consumer, the patient. A 42-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 18Aug2021 at 13:30 as a single dose for COVID-19 immunisation. Medical history included parathyroid gland excision and hypothyroidism. The patient previously took sulfur (MANUFACTURER UNKNOWN) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration as a single dose for COVID-19 immunisation. On 19Aug2021 at 00:00, the patient experienced right arm pain tingling to fingertips, under armpit pain, headache, hot, body aches, fatigue, low energy. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care.  Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events right arm pain tingling to fingertips, under armpit pain, headache, hot, body aches, fatigue, low energy was recovering at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling hot, Headache, Migraine
Clinical narrative: Dull headache; I felt really hot even under a ceiling fan and in an air conditioned room.; Intense, migraine like headache; Chills developed about an hour after the headache began.; This is a spontaneous report from a non-contactable consumer, the patient. A 44-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 59267-1000-01) via an unspecified route of administration in the left arm on 20Aug2021 at 10:15 (at the age of 44-year-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, it was unknown whether the patient was not diagnosed with COVID-19. The patient did not receive any vaccination within four weeks prior to the COVID vaccine. On 20Aug2021 at 12:45, the patient experienced intense, migraine like headache that improved after 4 hours to a dull headache. The patient felt really hot even under a ceiling fan and in an air-conditioned room and chills developed about hour after the headache began. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events intense, migraine like headache that improved after 4 hours to a dull headache, felt really hot and chills was resolving at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Dysphagia, Fatigue, Myalgia
Clinical narrative: Swelling of throat; Difficulty swallowing; Muscle/joint pain; Muscle/joint pain; Chill; Tired/run down; This is a spontaneous report from a non-contactable consumer, the patient. A 44-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 21Aug2021 at 14:45 (at the age of 44-year-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 21Aug2021 (also reported at 01:45), the patient experienced swelling of throat, difficulty swallowing, muscle/joint pain, chill, tired and run down. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swelling of throat, difficulty swallowing, muscle/joint pain, chill, tired was not resolved at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Pharyngeal swelling
Clinical narrative: Swelling of throat; Difficulty swallowing; Muscle/joint pain; Muscle/joint pain; Chill; Tired/run down; This is a spontaneous report from a non-contactable consumer, the patient. A 44-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 21Aug2021 at 14:45 (at the age of 44-year-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 21Aug2021 (also reported at 01:45), the patient experienced swelling of throat, difficulty swallowing, muscle/joint pain, chill, tired and run down. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swelling of throat, difficulty swallowing, muscle/joint pain, chill, tired was not resolved at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: Had a high stage fever at 103.5 and dropped after an hour; This is a spontaneous report from a contactable other healthcare professional, the patient. A 20-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 8448) via an intramuscular route of administration in the left arm on 20Aug2021 at 17:00 (at the age of 19-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient had no known allergies. Concomitant medications included unspecified anti-depressants medication and levonorgestrel (MIRENA) intrauterine device; both for unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 21Aug2021 at 17:30, the patient had a high stage fever at 103.5 and dropped after an hour. On the same day, the patient underwent body temperature test and the result was found to be 103.5 (unspecified units). The event high stage fever at 103.5 did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event high stage fever at 103.5 and dropped after an hour was resolving at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Intermenstrual bleeding, SARS-CoV-2 test, Vaginal haemorrhage
Clinical narrative: Sudden vaginal bleeding and spotting, not period; Spotting; This is a spontaneous report from a non-contactable consumer, the patient. An 18-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FD8448) via an unspecified route of administration on 18Aug2021 at 00:00 (at the age of 18-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. On 19Aug2021, the patient experienced sudden vaginal bleeding and spotting, not period. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Since the vaccination, the patient had been tested for COVID-19. On an unknown date, the patient underwent COVID-19 virus test and the result was negative. No therapeutic measures were taken as a result of the reported event. The clinical outcome of the event sudden vaginal bleeding and spotting, not period was not resolved at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Headache, Lymph node pain, Lymphadenopathy, Malaise
Clinical narrative: Upset stomach; General feeling of unwell ness; Extreme headache; Extremely swollen and painful lymph node above collar bone; Extremely swollen and painful lymph node above collar bone; This is a spontaneous report from a non-contactable consumer, the patient. A 29-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 18Aug2021 at 15:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included graves' disease and allergy to latex, gluten and sulfa based drugs. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient did not receive any concomitant medications. The patient previously received ciprofloxacin (CIPRO) and experienced drug allergy. On 22Aug2021, the patient experienced extreme headache 4 days after receiving shot. On 23Aug2021, the patient had upset stomach 5 days after shot. On 19Aug2021, the patient experienced extremely swollen and painful lymph node above collar bone. On 23Aug2021, the patient experienced general feeling of unwell ness 5 days after receiving shot. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. It was unknown whether any therapeutic measures were taken as a result of the events. The clinical outcome of the events extreme headache, upset stomach, extremely swollen and painful lymph node above collar bone, general feeling of unwell ness were not resolved at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Heart rate increased, Pain
Clinical narrative: Burning pain within an hour post vaccination that went all the way down arm into hand; Rapid heart beat; Headache; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0191) via an unspecified route of administration in the left arm on 05Aug2021 at 13:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included psoriatic arthritis. The patient previously received morphine (MANUFACTURER UNKNOWN) and pethidine hydrochloride (DEMEROL) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included hydrocodone (MANUFACTURER UNKNOWN) and leflunomide (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. On 05Aug2021 at 13:00, the patient experienced burning pain within an hour post vaccination that went all the way down his arm into hand. By night time the patient had a rapid heartbeat, headache and fatigue. This lasted a full week before it started to get better. The events did not result in doctor or other healthcare professional office/clinic visit/emergency visit. Therapeutic measures were not taken as a result of events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events burning pain within an hour post vaccination that went all the way down arm into hand, rapid heartbeat, headache and fatigue was recovered on an unknown date in Aug2021.  No follow-up attempts are needed. No further information is expected.
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Nausea, Pain, Pain in extremity, Pyrexia
Clinical narrative: Aching arm; Low grade fever; Headache; Nausea; Body aches; This is a spontaneous report from a non-contactable consumer, the patient. A 12-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FD8448) via an unspecified route of administration in the right arm on 16Aug2021 at 15:30 (at the age of 12-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included unspecified multivitamin for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 26Jul2021 at 12:00 (at the age of 12-years-old) as a single dose for COVID-19 immunisation. On 17Aug2021 at 12:00, the patient experienced aching arm, low grade fever, headache, nausea and body aches. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the adverse events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events aching arm, low grade fever, headache, nausea and body aches was resolved on an unknown date in Aug2021.   No follow-up attempts are possible. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy, Ultrasound scan
Clinical narrative: Swelling and tenderness of lymph nodes under left arm following injections; Swelling and tenderness of lymph nodes under left arm following injections; This is a spontaneous report from a non-contactable consumer, the patient. A 47-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date, as a single dose for COVID-19 immunisation. The patient also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 15Apr2021 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included unspecified birth control pills, sleeping pills and thyroid medications; all from unknown dates and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date, the patient experienced swelling and tenderness of lymph nodes under left arm following injections. The swelling and tenderness of lymph nodes under left arm where both shots were given was still continuing after 4 months. On an unknown date, the patient underwent lab test which included ultrasound and the result was not cancer or related to other infections. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events swelling and tenderness of lymph nodes under left arm following injections was not resolved at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain, Vaccination site pain
Clinical narrative: Tiredness; Soreness mainly at injection site, but mildly through out my body; Soreness mainly at injection site, but mildly through out my body; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3182) via an unspecified route of administration in the left arm on 18Aug2021 at 17:45 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 19Aug2021 at 07:00, the patient experienced tiredness, soreness mainly at injection site, but mildly throughout the body. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events tiredness, soreness mainly at injection site, but mildly throughout the body was resolved on an unknown date in Aug2021.   No follow-up attempts are possible. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Left arm was sore 11 days after getting the vaccine, after initial soreness has passed; This is a spontaneous report from a non-contactable consumer, the patient. A 42-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: fc3180) via an unspecified route of administration in the left arm on 12Aug2021 at 17:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included splenectomy and allergy to penicillin. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On an unknown date in Aug2021, the patient had initial soreness. On 22Aug2021, the patient's left arm was sore, 11 days after getting the vaccine, after initial soreness had passed. The event did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event left arm was sore 11 days after getting the vaccine, after initial soreness has passed was not resolved at the time of the report.   No follow-up attempts are possible. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Menstruation irregular
Clinical narrative: No period after both shots; This is a spontaneous report from a non-contactable consumer, the patient. A 39-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date, the patient experienced no period after both shots. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event no period after both shots was unknown at the time of report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Gastrooesophageal reflux disease, Muscle spasms, Pain, Throat irritation
Clinical narrative: Body hurts everywhere; Muscle spasms in arm and back close to ''my'' spine 5 days after getting the shot.; Acid reflex that is so bad it feels like its pushing on ''my'' heart.; Scratchy throat; Joint pain; This is a spontaneous report from a non-contactable consumer, the patient. A 26-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19Aug2021 at 15:00 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. On 24Aug2021 at 01:00, the patient experienced, muscle spasms in arm and back close to her spine 5 days after getting the shot. Acid reflex that was so bad it felt like it was pushing on her heart. She also experienced joint pain, scratchy throat and her body hurt everywhere. The event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were not taken as a result of the events. The clinical outcome of the events muscle spasms in arm and back close to her spine 5 days after getting the shot, acid reflex that was so bad it feels like it was pushing on her heart, joint pain, scratchy throat, body hurt everywhere was not resolved at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Diarrhea; This is a spontaneous report from a non-contactable consumer, the patient. A 68-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: NDC-59267-1000-01) via an unspecified route of administration on 22Aug2021 at 03:45 in the left arm (at the age of 68-years-old) as a single dose for COVID-19 immunisation. Medical history included shrimp allergy. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 26Jul2021 at 04:00 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. On 23Aug2021 at 16:00, the patient experienced diarrhea. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event diarrhea was resolving at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: All body hives lasting more than a month; This is a spontaneous report from a non-contactable consumer, the patient. A 24-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date (at the age of 24-year-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On an unknown date, the patient experienced all body hives lasting more than a month. The clinical outcome of the event all body hives lasting more than a month was unknown at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Breast pain, Chest pain, Decreased appetite, Fatigue, Migraine
Clinical narrative: Migraine; Vertigo; Pain in arm; Pain in arm chest; Pain in arm chest breast; Loss of appetite; Very tired; This is a spontaneous report from a non-contactable consumer, the patient. A 46-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FD8448) via an unspecified route of administration in the left arm on 22Aug2021 at 11:00 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included unspecified antibiotics (MANUFACTURER UNKNOWN), taken for an unspecified indication from an unknown date and unknown if ongoing. On 22Aug2021 at 14:30, the patient experienced migraine, vertigo, pain in arm, chest and breast, loss of appetite and very tired. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events migraine, vertigo, pain in arm, chest and breast, loss of appetite and very tired was not resolved at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vertigo
Clinical narrative: Migraine; Vertigo; Pain in arm; Pain in arm chest; Pain in arm chest breast; Loss of appetite; Very tired; This is a spontaneous report from a non-contactable consumer, the patient. A 46-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FD8448) via an unspecified route of administration in the left arm on 22Aug2021 at 11:00 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included unspecified antibiotics (MANUFACTURER UNKNOWN), taken for an unspecified indication from an unknown date and unknown if ongoing. On 22Aug2021 at 14:30, the patient experienced migraine, vertigo, pain in arm, chest and breast, loss of appetite and very tired. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events migraine, vertigo, pain in arm, chest and breast, loss of appetite and very tired was not resolved at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: Nausea; This is a spontaneous report from a non-contactable consumer, the patient. A 53-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 23Aug2021 at 19:00 (at the age of 53-year-old) as a single dose for COVID-19 immunisation. The patient's relevant medical history was not reported and had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included duloxetine hydrochloride (CYMBALTA), cetirizine hydrochloride (ZYRTEC) and esomeprazole sodium (NEXIUM); all for an unknown indication from an unknown date and unknown if ongoing. On 24Aug2021 at 02:00, the patient experienced nausea. The adverse event did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event nausea was resolved on 24Aug2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Stomatitis
Clinical narrative: Mouth sores; Headaches; Joint pain; This is a spontaneous report from a contactable healthcare professional, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWC178) via an unspecified route of administration in the right arm on 19Aug2021 at 08:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history and known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medication included unspecified multi vitamin (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. On 20Aug2021 at 11:15, the patient experienced mouth sores, headaches and joint pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events mouth sores, headaches and joint pain was not resolved at the time of this report.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Gait disturbance, Pain in extremity
Clinical narrative: Feet and toes hurt since being vaccinated; Difficult to walk; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0181) via an unspecified route of administration in the right arm on 15Jul2021 at 14:30 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. The patient's relevant medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other medications within two weeks of vaccination. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. On 19Jul2021, the patient experienced feet and toes hurt since being vaccinated, making it difficult to walk.  The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events feet and toes hurt and difficult to walk was not recovered at the time of this report.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Cough, Dyspnoea, Fatigue, Nausea
Clinical narrative: Sore arm; Mildly swollen arm; Weakness; Tiredness; Nausea; Vomiting; SOB; Cough; This is a spontaneous report from a contactable healthcare professional, the patient. A 28-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3181) via an unspecified route of administration in the right arm on 24Aug2021 at 17:45 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergy to sulfa. Prior to the vaccination, the patient was not diagnosed with COVID-19. It was unknown if patient was pregnant at the time of vaccination. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 24Aug2021 at 21:30, the patient experienced sore arm, mildly swollen arm, weakness, tiredness, nausea, vomiting, shortness of breath (SOB) and cough. Therapeutic measures were taken as a result of the events and included treatment with ibuprofen (MANUFACTURER UNKNOWN). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore arm, mildly swollen arm, weakness, tiredness, nausea, vomiting, shortness of breath and cough were not resolved at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Peripheral swelling, Vomiting
Clinical narrative: Sore arm; Mildly swollen arm; Weakness; Tiredness; Nausea; Vomiting; SOB; Cough; This is a spontaneous report from a contactable healthcare professional, the patient. A 28-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3181) via an unspecified route of administration in the right arm on 24Aug2021 at 17:45 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergy to sulfa. Prior to the vaccination, the patient was not diagnosed with COVID-19. It was unknown if patient was pregnant at the time of vaccination. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 24Aug2021 at 21:30, the patient experienced sore arm, mildly swollen arm, weakness, tiredness, nausea, vomiting, shortness of breath (SOB) and cough. Therapeutic measures were taken as a result of the events and included treatment with ibuprofen (MANUFACTURER UNKNOWN). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore arm, mildly swollen arm, weakness, tiredness, nausea, vomiting, shortness of breath and cough were not resolved at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Inappropriate schedule of product administration, Musculoskeletal pain
Clinical narrative: Pain in lower back/right glute; Pain in lower back/right glute; DOSE 1; 09Aug2021; Dose 2: 23Aug2021; This is a spontaneous report from a non-contactable consumer, the patient. A 41-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 23Aug2021 at 15:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history included bulging and degenerative disc and the patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 09Aug2021 at 11:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. On 23Aug2021 at 20:00, the patient experienced pain in lower back/right glute. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events pain in lower back/right glute was not resolved at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Chills, Dizziness, Ear pain, Fatigue
Clinical narrative: Hypertension; Lightheadedness/ Dizziness; Chest pain; Ear/jaw pain (same side as injection); Ear/jaw pain (same side as injection); Neck pressure (same side as injection); Whole arm numbness and pain (same side as injection); Whole arm numbness and pain (same side as injection); Leg cramping (same side as injection); Fatigue; Chills; This is a spontaneous report from a contactable healthcare professional, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FA7458) via an unspecified route of administration in the left arm on 03Aug2021 at 16:45 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 09Aug2021, the patient experienced hypertension, dizziness, light headedness, chest pain, ear and jaw pain, neck pressure, whole arm numbness and pain and leg cramping-all on same side of injection, fatigue and chills. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. On 04Aug2021, 14Aug2021 and 18Aug2021, the patient underwent Biofire/covid test through nasal swab and the results were negative. The clinical outcome of the events hypertension, dizziness, light headedness, chest pain, ear and jaw pain, neck pressure, whole arm numbness and pain and leg cramping-all on same side of injection, fatigue and chills was not resolved at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Hypertension, Hypoaesthesia, Muscle spasms, Musculoskeletal discomfort, Pain in extremity
Clinical narrative: Hypertension; Lightheadedness/ Dizziness; Chest pain; Ear/jaw pain (same side as injection); Ear/jaw pain (same side as injection); Neck pressure (same side as injection); Whole arm numbness and pain (same side as injection); Whole arm numbness and pain (same side as injection); Leg cramping (same side as injection); Fatigue; Chills; This is a spontaneous report from a contactable healthcare professional, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FA7458) via an unspecified route of administration in the left arm on 03Aug2021 at 16:45 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 09Aug2021, the patient experienced hypertension, dizziness, light headedness, chest pain, ear and jaw pain, neck pressure, whole arm numbness and pain and leg cramping-all on same side of injection, fatigue and chills. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. On 04Aug2021, 14Aug2021 and 18Aug2021, the patient underwent Biofire/covid test through nasal swab and the results were negative. The clinical outcome of the events hypertension, dizziness, light headedness, chest pain, ear and jaw pain, neck pressure, whole arm numbness and pain and leg cramping-all on same side of injection, fatigue and chills was not resolved at the time of this report.  No follow-up attempts are possible. No further information is expected.